Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals

Authors

  • David B. Menkes Waikato Clinical Campus, University of Auckland, Auckland, New Zealand
  • Deborah Gleeson School of Psychology and Public Health, La Trobe University, Melbourne, Australia
Abstract:

There is growing international concern about the risks posed by direct-to-consumer advertising (DTCA) of prescription pharmaceuticals, including via the internet. Recent trade agreements negotiated by the United States, however, incorporate provisions that may constrain national regulation of DTCA. Some provisions explicitly mention DTCA; others enable foreign investors to seek compensation if new regulations are seen to harm their investments. These provisions may thus prevent countries from restricting DTCA or put them at risk of expensive legal action from companies seeking damages due to restrictions on advertising. While the most recent example, the Trans-Pacific Partnership Agreement (TPP), collapsed following US withdrawal in January 2017, early indications of the Trump Administration’s trade policy agenda signal an even more aggressive approach on the part of the United States in negotiating advantages for American businesses. Furthermore, the eleven remaining TPP countries may decide to proceed with the agreement in the absence of the United States, with most of the original text (including the provisions relevant to DTCA) intact.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Ask Your Doctor? Direct-to-Consumer Advertising of Pharmaceuticals

We measure the impact of direct-to-consumer television advertising (DTCA) by drug manufacturers. Our identification strategy exploits shocks to local advertising markets generated by the political advertising cycle and a regulatory intervention affecting a single product. We find evidence of significant business stealing effects among branded, advertised drugs. In addition, we show positive spi...

full text

Direct-to-Consumer Pharmaceutical Advertising

Types of Advertisements There are currently several types of DTC drug advertisements (Table 1).5,11 One type is the “help-seeking ad,” which provides only information about a medical condition and encourages patients to contact their physician but doesn’t mention a product.5,11 Another category is the “reminder ad,” which includes the product name; this type may provide information about streng...

full text

Direct-to-consumer advertising of prescription drugs.

Starting consumers off on the "path to purchase" by encouraging them to seek more information is a major goal of direct-to-consumer (DTC) advertising for prescription medications. But the authors found that a consumer's attitude toward DTC advertising can determine which of several paths he or she is likely to take. The attitudes of older adults are especially significant for pharmaceutical mar...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue 2

pages  98- 100

publication date 2018-02-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023